XERIS BIOPHARMA HOLDINGS INC (XERS) Institutional Ownership Changes & 13F Activity
XERIS BIOPHARMA HOLDINGS INC (XERS). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Millennium Management Llc, Qube Research & Technologies Ltd, Jane Street Group, Llc, Bank Of America Corp, and Trexquant Investment Lp.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| State Street Corp | Buy | +163,392 | +3.5% | 4,821,566 | $38.19M | Q2 2026 | Sep 22, 2026 |
| Manufacturers Life Insurance Company, The | Buy | +1,900 | +2.6% | 74,704 | $591.66K | Q2 2026 | Sep 09, 2026 |
| Palogic Value Management, L.P. | Buy | +68 | +0.1% | 50,068 | $396.54K | Q2 2026 | Sep 09, 2026 |
| Allianz Asset Management Gmbh | Buy | +39,700 | — | 39,700 | $314.42K | Q2 2026 | Sep 02, 2026 |
| Citadel Advisors Llc | Sell | -17,070 | -2.5% | 664,564 | $5.26M | Q2 2026 | Sep 02, 2026 |
| Corient Private Wealth Llc | Buy | +184,126 | — | 184,126 | $1.46M | Q2 2026 | Aug 27, 2026 |
| California State Teachers Retirement System | Buy | +6,461 | +3.6% | 186,800 | $1.48M | Q2 2026 | Aug 24, 2026 |
| Mercer Global Advisors Inc | Buy | +11,522 | +67.8% | 28,510 | $225.80K | Q2 2026 | Aug 19, 2026 |
| Jefferies Financial Group Inc. | Buy | +205,870 | +234.5% | 293,670 | $2.33M | Q2 2026 | Aug 17, 2026 |
| Millennium Management Llc | Sell | -2,134,310 | -94.2% | 131,664 | $1.04M | Q2 2026 | Aug 14, 2026 |
| Qube Research & Technologies Ltd | Sell | -1,220,676 | -29.7% | 2,893,749 | $22.92M | Q2 2026 | Aug 14, 2026 |
| Jane Street Group, Llc | Sell | -663,701 | -91.5% | 61,915 | $490.37K | Q2 2026 | Aug 14, 2026 |
| Bank Of America Corp | Buy | +522,653 | +59.8% | 1,397,050 | $11.06M | Q2 2026 | Aug 14, 2026 |
| Trexquant Investment Lp | Sell | -494,104 | -59.3% | 339,113 | $2.69M | Q2 2026 | Aug 14, 2026 |
| Perceptive Advisors Llc | Buy | +467,013 | — | 467,013 | $3.70M | Q2 2026 | Aug 14, 2026 |
| Rosalind Advisors, Inc. | Sell | -322,719 | -10.0% | 2,908,981 | $23.04M | Q2 2026 | Aug 14, 2026 |
| Squarepoint Ops Llc | Sell | -248,819 | -40.5% | 365,731 | $2.90M | Q2 2026 | Aug 14, 2026 |
| Sei Investments Co | Sell | -239,701 | -41.4% | 339,509 | $2.69M | Q2 2026 | Aug 14, 2026 |
| Royce & Associates Lp | Buy | +205,066 | +80.1% | 461,153 | $3.65M | Q2 2026 | Aug 14, 2026 |
| Ishara Investments Lp | Buy | +205,000 | +20.0% | 1,230,000 | $9.74M | Q2 2026 | Aug 14, 2026 |
| Aquatic Capital Management Llc | Buy | +199,983 | — | 199,983 | $1.58M | Q2 2026 | Aug 14, 2026 |
| Hrt Financial Lp | Buy | +194,557 | +113.7% | 365,659 | $2.90M | Q2 2026 | Aug 14, 2026 |
| Wellington Management Group Llp | Buy | +193,749 | +8.9% | 2,365,103 | $18.73M | Q2 2026 | Aug 14, 2026 |
| Man Group Plc | Buy | +178,958 | +64.7% | 455,380 | $3.61M | Q2 2026 | Aug 14, 2026 |
| Voleon Capital Management Lp | Buy | +158,224 | +340.2% | 204,732 | $1.62M | Q2 2026 | Aug 14, 2026 |
| Canada Pension Plan Investment Board | Sell | -155,600 | -41.5% | 219,200 | $1.74M | Q2 2026 | Aug 14, 2026 |
| Aqr Capital Management Llc | Buy | +146,609 | +10.5% | 1,540,985 | $12.20M | Q2 2026 | Aug 14, 2026 |
| Susquehanna International Group, Llp | Sell | -146,153 | -51.1% | 139,918 | $1.11M | Q2 2026 | Aug 14, 2026 |
| Ameriprise Financial Inc | Buy | +143,285 | — | 143,285 | $1.13M | Q2 2026 | Aug 14, 2026 |
| Charles Schwab Investment Management Inc | Buy | +132,710 | +9.8% | 1,492,367 | $11.82M | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about XERS activity
Which institutional owners are buying XERS?
Institutional owners buying XERS include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in XERS activity?
"Buy" means an investor increased their reported position in XERS compared to the prior reporting period. This reflects growing exposure to XERIS BIOPHARMA HOLDINGS INC (XERS) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in XERS increasing?
Institutional interest in XERS can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related XERS Institutional Insights
- XERS Overview
- XERS 13F Institutional Holders
- XERS Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- XERS Insider Trading & SEC Form 4 Activity
- XERS Articles
- Top Institutional Investor Stock Rankings